| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.07T | 3.04T | 2.78T | 2.73T | 2.46T |
| Gross Profit | 1.01T | 908.86B | 849.21B | 804.77B | 796.97B |
| EBITDA | 427.54B | 398.03B | 322.94B | 305.00B | 350.77B |
| Net Income | 158.79B | 135.00B | 43.81B | -91.95B | 161.88B |
Balance Sheet | |||||
| Total Assets | 4.14T | 4.02T | 3.66T | 3.45T | 3.35T |
| Cash, Cash Equivalents and Short-Term Investments | 377.02B | 393.47B | 338.11B | 251.18B | 244.64B |
| Total Debt | 1.01T | 1.20T | 955.56B | 974.75B | 777.22B |
| Total Liabilities | 1.97T | 2.10T | 1.81T | 1.76T | 1.63T |
| Stockholders Equity | 2.09T | 1.86T | 1.81T | 1.66T | 1.69T |
Cash Flow | |||||
| Free Cash Flow | 109.43B | 99.81B | 147.59B | -61.17B | 41.02B |
| Operating Cash Flow | 303.10B | 301.49B | 295.30B | 90.80B | 183.27B |
| Investing Cash Flow | -88.87B | -364.84B | -142.60B | -212.09B | -221.02B |
| Financing Cash Flow | -263.35B | 128.25B | -94.33B | 110.28B | 42.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥15.31T | 30.35 | 11.19% | 2.17% | 0.50% | -6.23% | |
66 Neutral | ¥2.43T | 15.26 | 8.29% | 2.89% | 1.22% | 19.36% | |
64 Neutral | ¥875.08B | 20.61 | 4.79% | 4.21% | -4.09% | -27.31% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥3.39T | 95.28 | 4.42% | 1.00% | -3.97% | -4.31% | |
61 Neutral | ¥999.17B | 16.30 | 8.79% | 2.68% | -10.66% | 57.43% | |
53 Neutral | ¥1.52T | 133.33 | 1.09% | 3.50% | -15.96% | -74.31% |